Sep 24 |
Seelos Therapeutics announces the signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to evaluate SLS-002 for treatment of PTSD
|
Aug 23 |
Trials for psychedelic drug candidate for PTSD under scrutiny by FDA - report
|
Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Aug 16 |
Seelos Therapeutics files to sell 1.95M shares of common stock for holders
|
Aug 15 |
Lykos laying off 75% of workforce following FDA rejection of psychedelic drug for PTSD
|
Aug 15 |
Seelos: Q2 Earnings Snapshot
|
Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
Jul 10 |
Why VivoPower International Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
|
Jun 14 |
Seelos Therapeutics files to sell 924K shares of common stock for holders
|
Jun 4 |
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (updated)
|